Regulatory
Key facts
FDA authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System
Key facts
The device is intended for people aged 2 years and older living with diabetes
Key facts
The Libre Duo 10 Day is described by the FDA as the first wearable device in…
Atlas Watchline
The FDA authorized Abbott Diabetes Care’s Libre Duo 10 Day system for people age 2 and…